Tocilizumab efficacy in COVID-19 patients is associated with respiratory severity-based stages

Melchor Alvarez-Mon, Angel Asunsolo, José Sanz, Benjamin Muñoz, José Alberto Arranz-Caso, Maria Novella Mena, Cristina Hernández-Gutiérrez, Jorge Navarro, Maria Cristina Lozano Duran, Juan Arévalo Serrano, Rocío Henche Sanchez, Lara Bravo Quiroga, Julio Flores Segovia, Marta Garcia Sanchez, Aida Gutierrez Garcia, Ana Pérez, Marta Herrero, Nieves Plana, Daniel Troncoso, Gorjana Rackov, Carlos Martinez-A, Dimitrios Balomenos, for The Medicine-COVID19 HUPA group
doi: https://doi.org/10.1101/2021.03.04.21252167

Data Availability

All data generated and analyzed during this study are included in this article.

Back to top
Posted March 09, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Tocilizumab efficacy in COVID-19 patients is associated with respiratory severity-based stages
Melchor Alvarez-Mon, Angel Asunsolo, José Sanz, Benjamin Muñoz, José Alberto Arranz-Caso, Maria Novella Mena, Cristina Hernández-Gutiérrez, Jorge Navarro, Maria Cristina Lozano Duran, Juan Arévalo Serrano, Rocío Henche Sanchez, Lara Bravo Quiroga, Julio Flores Segovia, Marta Garcia Sanchez, Aida Gutierrez Garcia, Ana Pérez, Marta Herrero, Nieves Plana, Daniel Troncoso, Gorjana Rackov, Carlos Martinez-A, Dimitrios Balomenos, for The Medicine-COVID19 HUPA group
medRxiv 2021.03.04.21252167; doi: https://doi.org/10.1101/2021.03.04.21252167
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area